Jonathan Chung to Risk Assessment
This is a "connection" page, showing publications Jonathan Chung has written about Risk Assessment.
Connection Strength
0.177
-
CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features. AJR Am J Roentgenol. 2017 Jun; 208(6):1229-1236.
Score: 0.083
-
High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease. Sci Rep. 2021 11 24; 11(1):22821.
Score: 0.029
-
Performance of the right ventricular outflow tract/aortic diameter as a novel predictor of risk in patients with acute pulmonary embolism. J Thromb Thrombolysis. 2020 Jul; 50(1):165-173.
Score: 0.026
-
Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. J Clin Oncol. 2018 12 01; 36(34):3353-3360.
Score: 0.023
-
Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease. Circulation. 2014 Aug 19; 130(8):668-75.
Score: 0.017